Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Asparagine hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 D054198 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 D054198 ClinicalTrials
Leukemia 3 D007938 ClinicalTrials
Myeloproliferative Disorders 3 D009196 ClinicalTrials
Lymphoma, Non-Hodgkin 3 D008228 ClinicalTrials
Sarcoma, Myeloid 3 D023981 ClinicalTrials
Leukemia, Erythroblastic, Acute 3 D004915 ClinicalTrials
Leukemia, Myelomonocytic, Acute 3 D015479 ClinicalTrials
Leukemia, Megakaryoblastic, Acute 3 D007947 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Anemia, Refractory 3 D000753 ClinicalTrials
Anemia, Refractory, with Excess of Blasts 3 D000754 ClinicalTrials
Leukemia, Myelomonocytic, Chronic 3 D015477 ClinicalTrials
Leukemia, Monocytic, Acute 3 D007948 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Myelodysplastic Syndromes 3 D009190 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 D054218 ClinicalTrials
Leukemia, Basophilic, Acute 3 D015471 ClinicalTrials
Leukemia, Biphenotypic, Acute 2 D015456 ClinicalTrials
Leukemia, Lymphoid 2 D007945 ClinicalTrials
Leukemia, Biphenotypic, Acute 2 D015456 ClinicalTrials
Leukemia, Biphenotypic, Acute 2 D015456 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Immune system disorders
42.51
Vascular disorders
11.19
Blood and lymphatic system disorders
5.82
Gastrointestinal disorders
5.37
Infections and infestations
5.37
Injury, poisoning and procedural complications
5.37
Investigations
3.36
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.36
General disorders and administration site conditions
3.13
Respiratory, thoracic and mediastinal disorders
3.13
Pregnancy, puerperium and perinatal conditions
2.91
Hepatobiliary disorders
2.01

Cross References

Resources Reference
CAS NUMBER 9015-68-3
ChEMBL CHEMBL2108989
FDA SRS G4FQ3CKY5R